Upload
Featured Recent Articles Topics Login Upload

Search Results for 'statin ldl'

statin ldl published presentations and documents on DocSlides.

Statin Side effects   Active treatment
Statin Side effects   Active treatment
by ximena
Control. Relative risk. Absolute Effect. (per thou...
LDL is causal of atherosclerosis
LDL is causal of atherosclerosis
by morgan
Evidence from . meta-analyses of . Mendelian. . r...
Statin Adherence Purpose
Statin Adherence Purpose
by ivy
Outline the issue of medication nonadherence and r...
Statin Management in High Risk Groups: 2018 ACC/AHA Guideline on the Management of Blood Cholestero
Statin Management in High Risk Groups: 2018 ACC/AHA Guideline on the Management of Blood Cholestero
by jocelyn
Purpose. Outline highlights from the 2018 ACC/AHA ...
In The Name Of God Dyslipidemia
In The Name Of God Dyslipidemia
by PinkPandaBear
/Lipid management in . Diabetes. Dr.Zahra. . davo...
The State of
The State of
by olivia-moreira
Dyslipidemia. . Treatment. USA-145-101385. © . ...
Cholesterol Treatment Trialists’ (CTT) Collaboration
Cholesterol Treatment Trialists’ (CTT) Collaboration
by briana-ranney
Slide deck. CTT Collaboration: Background*. Histo...
Risk factors in heart disease
Risk factors in heart disease
by faustina-dinatale
Optimizing . patient care. William Cromwell, MD, ...
Update: Lipid Guidelines
Update: Lipid Guidelines
by yoshiko-marsland
DO NOT BURN THE COOKIES. Amy R. Woods, M.D.. a. ...
PCSK-9 Inhibitors Paul J
PCSK-9 Inhibitors Paul J
by tatyana-admore
PCSK-9 Inhibitors Paul J Kovack , DO, FACC, FACO...
The New Cholesterol Guidelines:
The New Cholesterol Guidelines:
by lily
Beauty is in the Eye of the Beholder. Brian Asbill...
Lipid Treatment Updates in Management
Lipid Treatment Updates in Management
by TheCookieMonster
Debra Griner, MS FNP-C. Mesa Primary Care. Casper,...
Putting Your Skills to the Test
Putting Your Skills to the Test
by deborah
Which ONE of the following statements regarding th...
Treatment of Blood Cholesterol
Treatment of Blood Cholesterol
by daniella
to Reduce Atherosclerotic Cardiovascular . Risk in...
In the Name of God Management
In the Name of God Management
by genevieve
of. Dyslipidemia. Navid Saadat, MD. Associate Pro...
Update on Clinical Trials:
Update on Clinical Trials:
by adia
How Will This Affect Practice in the Future?. Pame...
SWL lipid management guideline update- Highlights
SWL lipid management guideline update- Highlights
by finley
 . Pedro Bandeira. Specialist Pharmacist- Cardiov...
Is lower better? LDL targets and beyond.
Is lower better? LDL targets and beyond.
by olivia-moreira
Implications of the relationship between risk fac...
Is lower better? LDL targets and beyond.
Is lower better? LDL targets and beyond.
by trish-goza
Implications of the relationship between risk fac...
PCSK9 Inhibition: LDL Lowering
PCSK9 Inhibition: LDL Lowering
by SweetiePie
PCSK9 inhibitors. New option for dyslipidemia. Ali...
Implementing UCLPartners Familial Hypercholesterolemia Searches and Screening
Implementing UCLPartners Familial Hypercholesterolemia Searches and Screening
by ceila
Dr Deep Shah, . Clinical. . Lead UCL Partners. Do...
American Heart Association, November 13, 2023, Philadelphia, PA
American Heart Association, November 13, 2023, Philadelphia, PA
by bella
Inflammation and Cholesterol as Predictors of Card...
National Lipid Association
National Lipid Association
by taylor
Recommendations for Patient-Centered Management of...
2013 ACC/AHA Guidelines:
2013 ACC/AHA Guidelines:
by belinda
Blood . Cholesterol And. Assessment of Cardiovascu...
USAGE:
USAGE:
by celsa-spraggs
. U. nderstanding . S. tatin Use in . A. merica ...
Updates on the Management of Dyslipidemia
Updates on the Management of Dyslipidemia
by ellena-manuel
A Review of the 2013 ACC/AHA Cholesterol Guidelin...
Protecting the heart and the kidney:
Protecting the heart and the kidney:
by pressio
Implications from the SHARP trial. Dr. Christina R...
Dyslipidemia (Med-3) Dr Anwar A Jammah
Dyslipidemia (Med-3) Dr Anwar A Jammah
by bety
, MD, FRCPC, FACP, CCD, ECNU.. Associate . Profess...
Trial Design Evolocumab SC
Trial Design Evolocumab SC
by danika-pritchard
140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...
New developments in lipid management
New developments in lipid management
by pasty-toler
CGR 0800 h 11 May 2015. Rob Hegele MD FRCPC FACP....
The Importance of Potential
The Importance of Potential
by pamella-moone
Statin. in High Risk Patient. Masrul Syafri. Bag...
Cholesterol-Lowering Drugs
Cholesterol-Lowering Drugs
by cheryl-pisano
Victor Nadler. Objectives. By the end of this cla...
FOURIER F urther cardiovascular
FOURIER F urther cardiovascular
by trish-goza
OU. tcomes. . R. esearch with PCSK9 . I. nhibiti...
Hypertension & Cholesterol
Hypertension & Cholesterol
by cheryl-pisano
Blake Wachter, MD, PhD. Idaho Heart Institute. Ep...
Protecting the heart and the kidney:
Protecting the heart and the kidney:
by marina-yarberry
Implications from the SHARP trial. Dr. Christina ...
DIABETES AND LIPID
DIABETES AND LIPID
by yoshiko-marsland
S-KHALILZADEH. Lipids are hydrophobic molecules t...
Rational Order of Laboratory Tests in Cardiovascular Diseases
Rational Order of Laboratory Tests in Cardiovascular Diseases
by carneos
Sedighe. . S. adat . Ghorashi. . MD. Family Medic...
D yslipidemia Objectives :
D yslipidemia Objectives :
by arya
 Know the clinical terminology for . dyslipidemia...
DYSLIPIDEMIA IN DIABETES
DYSLIPIDEMIA IN DIABETES
by esther
MAHTAB NIROOMAND M.D.. Assistant professor of End...
D yslipidemia DR,DUAA HIASAT
D yslipidemia DR,DUAA HIASAT
by mackenzie
Objectives :.  Know the clinical terminology for ...